Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease.

Spanos C, Maldonado EM, Fisher CP, Leenutaphong P, Oviedo-Orta E, Windridge D, Salguero FJ, Bermúdez-Fajardo A, Weeks ME, Evans C, Corfe BM, Rabbani N, Thornalley PJ, Miller MH, Wang H, Dillon JF, Quaglia A, Dhawan A, Fitzpatrick E, Moore JB.

Proteome Sci. 2018 Jun 25;16:13. doi: 10.1186/s12953-018-0142-8. eCollection 2018.

2.

Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease.

Spanos C, Maldonado EM, Fisher CP, Leenutaphong P, Oviedo-Orta E, Windridge D, Salguero FJ, Bermúdez-Fajardo A, Weeks ME, Evans C, Corfe BM, Rabbani N, Thornalley PJ, Miller MH, Wang H, Dillon JF, Quaglia A, Dhawan A, Fitzpatrick E, Bernadette Moore J.

Proteome Sci. 2018 Feb 14;16:4. doi: 10.1186/s12953-018-0131-y. eCollection 2018. Erratum in: Proteome Sci. 2018 Jun 25;16:13.

3.

Design and evaluation of the immunogenicity and efficacy of a biomimetic particulate formulation of viral antigens.

Riitho V, Walters AA, Somavarapu S, Lamp B, Rümenapf T, Krey T, Rey FA, Oviedo-Orta E, Stewart GR, Locker N, Steinbach F, Graham SP.

Sci Rep. 2017 Oct 23;7(1):13743. doi: 10.1038/s41598-017-13915-x.

4.

Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines.

Oviedo-Orta E, Ahmed S, Rappuoli R, Black S.

Vaccine. 2015 Jul 17;33(31):3628-35. doi: 10.1016/j.vaccine.2015.06.046. Epub 2015 Jun 17. Review.

PMID:
26093201
5.

Surveillance for Neisseria meningitidis Disease Activity and Transmission Using Information Technology.

Ahmed SS, Oviedo-Orta E, Mekaru SR, Freifeld CC, Tougas G, Brownstein JS.

PLoS One. 2015 May 20;10(5):e0127406. doi: 10.1371/journal.pone.0127406. eCollection 2015.

6.

Connexin40 regulates platelet function.

Vaiyapuri S, Moraes LA, Sage T, Ali MS, Lewis KR, Mahaut-Smith MP, Oviedo-Orta E, Simon AM, Gibbins JM.

Nat Commun. 2013;4:2564. doi: 10.1038/ncomms3564.

7.

Perspectives on vaccine development for the elderly.

Oviedo-Orta E, Li CK, Rappuoli R.

Curr Opin Immunol. 2013 Aug;25(4):529-34. doi: 10.1016/j.coi.2013.07.008. Epub 2013 Aug 31. Review.

PMID:
24001371
8.

Protective efficacy induced by recombinant Clostridium difficile toxin fragments.

Leuzzi R, Spencer J, Buckley A, Brettoni C, Martinelli M, Tulli L, Marchi S, Luzzi E, Irvine J, Candlish D, Veggi D, Pansegrau W, Fiaschi L, Savino S, Swennen E, Cakici O, Oviedo-Orta E, Giraldi M, Baudner B, D'Urzo N, Maione D, Soriani M, Rappuoli R, Pizza M, Douce GR, Scarselli M.

Infect Immun. 2013 Aug;81(8):2851-60. doi: 10.1128/IAI.01341-12. Epub 2013 May 28.

9.

A novel transport mechanism for MOMP in Chlamydophila pneumoniae and its putative role in immune-therapy.

Atanu FO, Oviedo-Orta E, Watson KA.

PLoS One. 2013 Apr 24;8(4):e61139. doi: 10.1371/journal.pone.0061139. Print 2013.

10.

Therapeutic vaccines and immunotherapies: current challenges and new frontiers.

Oviedo-Orta E, Plotkin SA, Ulmer JB, Ahmed SS.

Expert Rev Vaccines. 2013 Mar;12(3):243-4. doi: 10.1586/erv.13.29. No abstract available.

PMID:
23496662
11.

Immune responses elicited by apoB-100-derived peptides in mice.

Pierides C, Bermudez-Fajardo A, Fredrikson GN, Nilsson J, Oviedo-Orta E.

Immunol Res. 2013 May;56(1):96-108. doi: 10.1007/s12026-013-8383-1.

PMID:
23345063
12.

Human papillomavirus E2 protein: a potential key regulator of viral cell pathogenesis.

Oviedo-Orta E, Ahmed SS, Rappuoli R.

Pathog Glob Health. 2012 Jul;106(3):141. doi: 10.1179/204777312X13462106637765. No abstract available.

13.

Vaccines and antibiotic resistance.

Mishra RP, Oviedo-Orta E, Prachi P, Rappuoli R, Bagnoli F.

Curr Opin Microbiol. 2012 Oct;15(5):596-602. doi: 10.1016/j.mib.2012.08.002. Epub 2012 Sep 12. Review.

PMID:
22981392
14.

Gap junctions and connexin hemichannels underpin hemostasis and thrombosis.

Vaiyapuri S, Jones CI, Sasikumar P, Moraes LA, Munger SJ, Wright JR, Ali MS, Sage T, Kaiser WJ, Tucker KL, Stain CJ, Bye AP, Jones S, Oviedo-Orta E, Simon AM, Mahaut-Smith MP, Gibbins JM.

Circulation. 2012 May 22;125(20):2479-91. doi: 10.1161/CIRCULATIONAHA.112.101246. Epub 2012 Apr 23.

15.

Influenza vaccination promotes stable atherosclerotic plaques in apoE knockout mice.

Bermúdez-Fajardo A, Oviedo-Orta E.

Atherosclerosis. 2011 Jul;217(1):97-105. doi: 10.1016/j.atherosclerosis.2011.03.019. Epub 2011 Mar 29.

PMID:
21507404
16.

Progress in understanding adjuvant immunotoxicity mechanisms.

Batista-Duharte A, Lindblad EB, Oviedo-Orta E.

Toxicol Lett. 2011 Jun 10;203(2):97-105. doi: 10.1016/j.toxlet.2011.03.001. Epub 2011 Mar 15. Review.

PMID:
21392560
17.

The effect of Chlamydophila pneumoniae Major Outer Membrane Protein (MOMP) on macrophage and T cell-mediated immune responses.

Bermudez-Fajardo A, Stark AK, El-Kadri R, Penichet ML, Hölzle K, Wittenbrink MM, Hölzle L, Oviedo-Orta E.

Immunobiology. 2011 Jan-Feb;216(1-2):152-63. doi: 10.1016/j.imbio.2010.06.004. Epub 2010 Jun 22.

PMID:
20637522
18.

Control of the proliferation of activated CD4+ T cells by connexins.

Oviedo-Orta E, Perreau M, Evans WH, Potolicchio I.

J Leukoc Biol. 2010 Jul;88(1):79-86. doi: 10.1189/jlb.0909613. Epub 2010 Mar 16.

PMID:
20233983
19.

Effect of 2-amino-9H-pyrido[2,3-b]indole (AalphaC), a carcinogenic heterocyclic amine present in food, on atherosclerotic plaque development in apoE deficient mice.

Lopez-Mendez C, Bermudez-Fajardo A, Ioannides C, Oviedo-Orta E.

Toxicol Lett. 2009 Mar 10;185(2):73-8. doi: 10.1016/j.toxlet.2008.11.014. Epub 2008 Dec 3.

PMID:
19103270
20.

Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.

Milioti N, Bermudez-Fajardo A, Penichet ML, Oviedo-Orta E.

Clin Dev Immunol. 2008;2008:723539. doi: 10.1155/2008/723539. Review.

21.

Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages.

Oviedo-Orta E, Bermudez-Fajardo A, Karanam S, Benbow U, Newby AC.

Immunology. 2008 May;124(1):42-50. Epub 2007 Oct 19.

22.

CD4+ T lymphocyte subsets express connexin 43 and establish gap junction channel communication with macrophages in vitro.

Bermudez-Fajardo A, Ylihärsilä M, Evans WH, Newby AC, Oviedo-Orta E.

J Leukoc Biol. 2007 Sep;82(3):608-12. Epub 2007 Jun 27.

23.

Gap junctions and connexin-mediated communication in the immune system.

Oviedo-Orta E, Howard Evans W.

Biochim Biophys Acta. 2004 Mar 23;1662(1-2):102-12. Review.

24.

Gap junctions and connexins: potential contributors to the immunological synapse.

Oviedo-Orta E, Evans WH.

J Leukoc Biol. 2002 Oct;72(4):636-42. Review.

PMID:
12377931
25.

Gap junction intercellular communication during lymphocyte transendothelial migration.

Oviedo-Orta E, Errington RJ, Evans WH.

Cell Biol Int. 2002;26(3):253-63.

PMID:
11991653
26.

Supplemental Content

Loading ...
Support Center